We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+10.92%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$853M
AUM Growth
-$19.3M
Cap. Flow
-$81.6M
Cap. Flow %
-9.56%
Top 10 Hldgs %
13.72%
Holding
1,104
New
422
Increased
110
Reduced
108
Closed
462

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$14M
2
NKE icon
Nike
NKE
+$11.7M
3
MDB icon
MongoDB
MDB
+$9.23M
4
TXN icon
Texas Instruments
TXN
+$8M
5
FTNT icon
Fortinet
FTNT
+$7.77M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$39.5M
2
ACN icon
Accenture
ACN
+$13.2M
3
ULTA icon
Ulta Beauty
ULTA
+$11.4M
4
ADBE icon
Adobe
ADBE
+$11.3M
5
TSLA icon
Tesla
TSLA
+$9.53M

Sector Composition

Rank Sector Weight
1 Technology 25.51%
2 Consumer Discretionary 16.21%
3 Healthcare 10.72%
4 Industrials 10.26%
5 Financials 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OLPX
626
DELISTED
Olaplex Holdings
OLPX
$46K 0.01%
19,554
-12,300
-39% -$24.9K
IQ icon
627
iQIYI
IQ
$889M
$45.2K 0.01%
+15,800
New +$45.9K
OSUR icon
628
OraSure Technologies
OSUR
$249M
$44.4K 0.01%
+10,400
New +$44.7K
BTBT icon
629
Bit Digital
BTBT
$519M
$44.2K 0.01%
+12,600
New +$41.9K
NGD
630
DELISTED
New Gold Inc
NGD
$40.7K ﹤0.01%
+14,120
New +$34.9K
ERAS icon
631
Erasca
ERAS
$6.33B
$36K ﹤0.01%
+13,200
New +$37.2K
AMLX icon
632
Amylyx Pharmaceuticals
AMLX
$3.84B
$34.7K ﹤0.01%
+10,700
New +$24.1K
RXT icon
633
Rackspace Technology
RXT
$798M
$29.7K ﹤0.01%
+12,141
New +$29.3K
MCRB icon
634
Seres Therapeutics
MCRB
$50.8M
$29.3K ﹤0.01%
+1,550
New +$31.4K
FUBO icon
635
FuboTV Inc
FUBO
$311M
$29.3K ﹤0.01%
+1,717
New +$31K
XFOR icon
636
X4 Pharmaceuticals
XFOR
$400M
$25.7K ﹤0.01%
+1,280
New +$26.7K
REKR icon
637
Rekor Systems
REKR
$74.9M
$20.8K ﹤0.01%
+17,600
New +$25.9K
CXAI icon
638
CXApp
CXAI
$8.46M
$19.5K ﹤0.01%
+232
New +$24.1K
ACET icon
639
Adicet Bio
ACET
$84.8M
$18.2K ﹤0.01%
789
-737
-48% -$16.5K
SKIN icon
640
SkinHealth Systems
SKIN
$89.1M
$18.1K ﹤0.01%
12,538
-29,500
-70% -$48.3K
GEVO icon
641
Gevo
GEVO
$418M
$17K ﹤0.01%
+10,400
New +$8.43K
SCLX icon
642
Scilex Holding
SCLX
$38.2M
$16.6K ﹤0.01%
+511
New +$24.5K
ACAD icon
643
Acadia Pharmaceuticals
ACAD
$5B
-36,000
Closed -$585K
ACCO icon
644
Acco Brands
ACCO
$397M
-12,396
Closed -$58.3K
ACIW icon
645
ACI Worldwide
ACIW
$5.46B
-5,900
Closed -$234K
ACN icon
646
Accenture
ACN
$116B
-43,600
Closed -$13.2M
ADM icon
647
Archer Daniels Midland
ADM
$39.2B
-7,001
Closed -$423K
ADMA icon
648
ADMA Biologics
ADMA
$2.1B
-15,615
Closed -$175K
ADVM
649
DELISTED
Adverum Biotechnologies
ADVM
-10,756
Closed -$73.8K
AGEN
650
Agenus
AGEN
$347M
-10,525
Closed -$176K

Similar funds

Bayesian Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Bayesian Capital Management held 1,104 positions worth $853M, down 2.2% from $873M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Bayesian Capital Management withdrew a net $81.6M in Q3 2024, closing 462 positions and reducing 108 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $39.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in MongoDB worth $9.61M.

  • Bayesian Capital Management's largest Q3 2024 buy was MongoDB: 35,529 shares worth $9.61M.
  • Bayesian Capital Management added most to Netflix in Q3 2024, an estimated $14M increase.
  • Bayesian Capital Management's biggest Q3 2024 reduction was Adobe, cutting an estimated $11.3M.
  • Bayesian Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q3 2024, selling an estimated $39.5M.
  • Bayesian Capital Management's ten largest holdings make up 14% of its $853M portfolio in Q3 2024.
  • Bayesian Capital Management opened 422 new positions and closed 462 in Q3 2024.
  • Bayesian Capital Management's portfolio value fell 2.2% quarter-over-quarter to $853M.

Based on Bayesian Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.